Skip to main content

Application of Proteomic Analysis to the Study of Azole Antifungal Resistance in Candida albicans

  • Protocol
Antifungal Agents

Part of the book series: Methods in Molecular Medicineā„¢ ((MIMM,volume 118))

  • 712 Accesses

Abstract

The sequencing of the Candida albicans genome and recent refinements in protein resolution and identification techniques have greatly enhanced the application of proteomics for the study of this fungal pathogen. Proteome analysis includes the separation and isolation of proteins by two-dimensional polyacrylamide gel electrophoresis and subsequent protein identification by peptide mass fingerprinting using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. This technique has been used for the study of the proteomes of Candida species in the context of virulence, drug response, and resistance. We describe here the application of this approach to the study of azole antifungal resistance in C. albicans.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Valdes I, Pitarch, A., Gil, C., et al. (2000) Novel procedure for the identification of proteins by mass fingerprinting combining two-dimensional electrophoresis with fluorescent SYPRO red staining. J. Mass Spectrom. 35, 672ā€“682.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  2. Marichal, P., Vanden Bossche, H., Odds, F. C., et al. (1997) Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 41, 2229ā€“2237.

    PubMedĀ  CASĀ  Google ScholarĀ 

  3. Niimi, M., Nagai, Y., Niimi, K., et al. (2002) Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 782, 245ā€“252.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  4. Hooshdaran, M. Z., Barker, K. S., Hilliard, G. M., et al. (2004) Proteomic analysis of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 48, 2733ā€“2735.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  5. Kusch, H., Biswas, K., Schwanfelder, S., et al. (2004) A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol. Genet. Genomics. 271, 554ā€“565.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  6. Bruneau, J. M., Maillet, I., Tagat, E., et al. (2003) Drug induced proteome changes in Candida albicans: comparison of the effect of beta(1,3) glucan synthase inhibitors and two triazoles, fluconazole and itraconazole. Proteomics. 3, 325ā€“336.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  7. Graves, P. R., and Haystead, T. A. (2002) Molecular biologistā€™s guide to proteomics. Microbiol. Mol. Biol. Rev. 66, 39ā€“63.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  8. Niimi, M., Cannon, R. D., and Monk, B. C. (1999) Candida albicans pathogenicity: a proteomic perspective. Electrophoresis 20, 2299ā€“2308.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  9. Pitarch, A., Sanchez, M., Nombela, C., and Gil, C. (2003) Analysis of the Candida albicans proteome. I. Strategies and applications. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787, 101ā€“128.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  10. Pitarch, A., Sanchez, M., Nombela, C., and Gil, C. (2003) Analysis of the Candida albicans proteome. II. Protein information technology on the Net (update 2002). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 787, 129ā€“148.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  11. MorschhƤuser, J. (2002). The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587, 240ā€“248.

    PubMedĀ  Google ScholarĀ 

  12. White, T. C., Marr, K. A., and Bowden, R. A. (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11, 382ā€“402.

    PubMedĀ  CASĀ  Google ScholarĀ 

  13. Sanglard, D. (2002) Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol. 5, 379ā€“385.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  14. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal. Chem. 68, 850ā€“858.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  15. Wilm, M., Shevchenko, A., Houthaeve, T., et al. (1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466ā€“469.

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2005 Humana Press Inc.

About this protocol

Cite this protocol

Hooshdaran, M.Z., Hilliard, G.M., Rogers, P.D. (2005). Application of Proteomic Analysis to the Study of Azole Antifungal Resistance in Candida albicans . In: Ernst, E.J., Rogers, P.D. (eds) Antifungal Agents. Methods in Molecular Medicineā„¢, vol 118. Humana Press. https://doi.org/10.1385/1-59259-943-5:057

Download citation

  • DOI: https://doi.org/10.1385/1-59259-943-5:057

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-277-3

  • Online ISBN: 978-1-59259-943-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics